Green Lifescience バランスシートの健全性
財務の健全性 基準チェック /56
Green Lifescience has a total shareholder equity of ₩36.7B and total debt of ₩4.8B, which brings its debt-to-equity ratio to 13.1%. Its total assets and total liabilities are ₩44.1B and ₩7.4B respectively.
主要情報
13.1%
負債資本比率
₩4.80b
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | ₩12.73b |
| エクイティ | ₩36.70b |
| 負債合計 | ₩7.37b |
| 総資産 | ₩44.08b |
財務の健全性に関する最新情報
Health Check: How Prudently Does Green Lifescience (KOSDAQ:114450) Use Debt?
Mar 26
KPX Lifescience.Co.Ltd (KOSDAQ:114450) Has Debt But No Earnings; Should You Worry?
Feb 22Recent updates
Green Lifescience Co., Ltd.'s (KOSDAQ:114450) 36% Dip In Price Shows Sentiment Is Matching Revenues
Sep 13The Market Doesn't Like What It Sees From Green Lifescience Co., Ltd.'s (KOSDAQ:114450) Revenues Yet
Jul 30Health Check: How Prudently Does Green Lifescience (KOSDAQ:114450) Use Debt?
Mar 26KPX Lifescience.Co.Ltd (KOSDAQ:114450) Has Debt But No Earnings; Should You Worry?
Feb 22Investors Who Bought KPX Lifescience.Co.Ltd (KOSDAQ:114450) Shares Three Years Ago Are Now Up 180%
Dec 31
財務状況分析
短期負債: A114450's short term assets (₩21.8B) exceed its short term liabilities (₩6.9B).
長期負債: A114450's short term assets (₩21.8B) exceed its long term liabilities (₩488.9M).
デット・ツー・エクイティの歴史と分析
負債レベル: A114450 has more cash than its total debt.
負債の削減: A114450's debt to equity ratio has increased from 9.2% to 13.1% over the past 5 years.
貸借対照表
キャッシュ・ランウェイ分析
過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。
安定したキャッシュランウェイ: Whilst unprofitable A114450 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
キャッシュランウェイの予測: A114450 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 5.2% per year.